Cohen Milstein代表Northwest Biotherapeutics对主要做市商操纵市场提起诉讼
NEW YORK, Dec 3, 2022 – (亚太商讯 via SEAPRWire.com) – 今天，Northwest Biotherapeutics（OTCQB：NWBO）对世界上一些最大和最有影响力的做市...
君联资本联合创建企业朗信生物遗传性视网膜变性基因治疗产品在中国获批临床
HONG KONG, Apr 24, 2022 – (亚太商讯 via SEAPRWire.com) – 君联资本联合创建企业朗信生物（Innostellar Biotherapeutics Co.,Ltd）旗下上海...
Legend Capital’s Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
HONG KONG, Apr 24, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial […]